Lymphocyte immunotherapy in the treatment of recurrent miscarriage: systematic review and meta-analysis

[11] Kwak JY(1985)Controlled trial of treatment of recurrent spontaneous abortion by immunization with paternal cells Lancet 1 941-937

[12] Gilman-Sachs A(2013)Mixed lymphocyte reaction blocking factors (MLR-Bf) as potential biomarker for indication and efficacy of paternal lymphocyte immunization in recurrent spontaneous abortion Arch Gynecol Obstet 288 933-112

[13] Moretti M(2010)The expression of Th1- and Th2-related chemokine receptors in women with recurrent miscarriage: the impact of lymphocyte immunotherapy Am J Reprod Immunol 64 104-1068

[14] Beaman KD(2001)The influence of paternal lymphocytes immunization on percentage of peripheral blood CD16+/CD56+ cells in women with primary recurrent spontaneous abortion Ginekol Pol 72 1063-298

[15] Beer AE(2014)Alteration of Th17 and Treg cells in patients with unexplained recurrent spontaneous abortion before and after lymphocyte immunization therapy Reprod Biol Endocrinol 12 74-313

[16] Yokoo T(2004)Induction of MLR-Bf and protection of fetal loss: a current double blind randomized trial of paternal lynphocyte immunization for women with recurrent spontaneous abortion Int Immunopharmacol 4 289-164

[17] Takakuwa K(2004)Diagnosis and treatment of recurrent miscarriage associated with immunologic disorders: is paternal lymphocyte immunization a relic of the past J Nippon Med Sch 71 308-259

[18] Ooki I(2000)Immunoglobulin G infusion treatment for women with recurrent spontaneous abortions and elevated CD56+ natural killer cells Early Pregnancy 4 154-193

[19] Kikuchi A(1973)Effect of blood transfusions on subsequent kidney transplants Transplant Proc 5 253-859

[20] Tamura M(2012)The end of evidence-based medicine? Inflammopharmacol 20 187-280

[11] Kwak JY(1985)Controlled trial of treatment of recurrent spontaneous abortion by immunization with paternal cells Lancet 1 941-937

[12] Gilman-Sachs A(2013)Mixed lymphocyte reaction blocking factors (MLR-Bf) as potential biomarker for indication and efficacy of paternal lymphocyte immunization in recurrent spontaneous abortion Arch Gynecol Obstet 288 933-112

[13] Moretti M(2010)The expression of Th1- and Th2-related chemokine receptors in women with recurrent miscarriage: the impact of lymphocyte immunotherapy Am J Reprod Immunol 64 104-1068

[14] Beaman KD(2001)The influence of paternal lymphocytes immunization on percentage of peripheral blood CD16+/CD56+ cells in women with primary recurrent spontaneous abortion Ginekol Pol 72 1063-298

[15] Beer AE(2014)Alteration of Th17 and Treg cells in patients with unexplained recurrent spontaneous abortion before and after lymphocyte immunization therapy Reprod Biol Endocrinol 12 74-313

[16] Yokoo T(2004)Induction of MLR-Bf and protection of fetal loss: a current double blind randomized trial of paternal lynphocyte immunization for women with recurrent spontaneous abortion Int Immunopharmacol 4 289-164

[17] Takakuwa K(2004)Diagnosis and treatment of recurrent miscarriage associated with immunologic disorders: is paternal lymphocyte immunization a relic of the past J Nippon Med Sch 71 308-259

[18] Ooki I(2000)Immunoglobulin G infusion treatment for women with recurrent spontaneous abortions and elevated CD56+ natural killer cells Early Pregnancy 4 154-193

[19] Kikuchi A(1973)Effect of blood transfusions on subsequent kidney transplants Transplant Proc 5 253-859

[20] Tamura M(2012)The end of evidence-based medicine? Inflammopharmacol 20 187-280